Elanco Animal Health Reports Second Quarter Results, Including Strong EPS and Gross Margin Improvement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Elanco Animal Health (ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
August 13, 2019 8:22 AM EDTElanco Animal Health (NYSE: ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
Elanco Animal Health (ELAN) Tops Q2 EPS by 2c, Updates FY Guidance
August 13, 2019 6:37 AM EDTElanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $781.6 million versus the consensus estimate of $782.88 million.
GUIDANCE:
Elanco Animal Health sees FY2019 EPS of $1.04-$1.10, versus the... More
